Company Filing History:
8 out of 131,611 
1 out of 8 Years Active: 2015-2018
Title: **Innovative Contributions of Inventor Saet Byoul Lee**
Introduction
Saet Byoul Lee is a prominent inventor based in Seoul, South Korea, known for his groundbreaking work in the field of biomarker research and cancer therapy. With a total of eight patents to his name, Lee continues to push the boundaries of scientific innovation.
Latest Patents
Among Saet Byoul Lee's latest patents is the development of a biomarker, Hsp90, which is utilized for predicting the effect of a c-Met inhibitor. This invention offers a method for selecting appropriate subjects for c-Met inhibitor applications and monitoring the drug's efficacy. Additionally, Lee holds a patent for a combination therapy that employs a dual inhibitor of c-Met and EGFR along with an IGF-1R inhibitor. This method aims to prevent and treat cancer by co-administering these inhibitors and identifying IGF-1R as a marker for resistance to the dual therapy.
Career Highlights
Throughout his career, Saet Byoul Lee has made significant strides in the academic and corporate sectors. He is notably associated with Samsung Electronics Co., Ltd. and the Samsung Life Welfare Foundation, where he has applied his expertise in biotechnology and therapeutic innovation.
Collaborations
Lee has collaborated with talented individuals including Kyung Ah Kim and Ji Min Lee, contributing to the advancement of innovative therapies. Their work together exemplifies the power of teamwork and diverse expertise in the scientific community.
Conclusion
Saet Byoul Lee stands out as an influential inventor whose contributions significantly impact cancer treatment and biomarker utilization. His ongoing work fosters hope for continued advancements in medical science, paving the way for more effective therapies and improved patient outcomes.